Academic Highlights: International Consensus Group on Bipolar I Depression Treatment Guidelines
J Clin Psychiatry 2004;65(4):569-579
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Click to enlarge page
Dr. Calabrese began the meeting by saying that in the management of7 bipolar disorder the guidelines available for treating mania are fairly standard worldwide. However, the guidelines for treating bipolar depression vary, sometimes substantially, from country to country. Therefore, the primary aim of the consensus group was to discuss the treatment of bipolar I depression across different countries and develop a consensus on international treatment guidelines for this phase of the illness. The group sought to formulate its recommendations on the basis of the available clinical evidence, rather than relying on expert opinion as is the case with some guidelines, given the numerous agents being studied for bipolar depression in well-designed clinical trials.